Bluejay Diagnostics regains Nasdaq minimum bid price compliance after reverse stock split

Bluejay Diagnostics, Inc.

Received Nasdaq notification on Aug 8, 2023 that minimum bid price deficiency is closed.
Reverse stock split executed on July 24, 2023 to help regain compliance.
Closing bid price was at least $1.00 for ten consecutive business days.
Original deficiency was reported on October 25, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.